Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability

Journal of Neurochemistry

Volumn 93, Issue 2, 2005, Pages 502-512

  Wei, Fan Yan ^a   Tomizawa, Kazuhito ^b   Ohshima, Toshio ^c   Asada, Akiko ^a   Saito, Taro ^a   Nguyen, Chan ^d   Bibb, James A ^d   Ishiguro, Koichi ^e   Kulkarni, Ashok B ^f   Pant, Harish C ^g   Mikoshiba, Katsuhiko ^c   Matsui, Hideki ^b   Hisanaga, Shin Ichi ^a  

^a TOKYO METROPOLITAN UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c Brain Science Institute   (Japan)

^d Univ of TX S W Medical Center   (United States)

^e MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

^f Natl Inst Dent Craniofacial Res   (United States)

^g NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Calmodulin; Cyclin dependent kinase 5; Glutamate; Long term potentiation; N methyl D aspartate; Proteasome

Indexed keywords

CALCIUM; CALMODULIN; CYCLIN DEPENDENT KINASE 5; GLUTAMIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; PROTEIN P35;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; BRAIN DEPTH STIMULATION; BRAIN SLICE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HIPPOCAMPUS; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; MICE; MICE, INBRED ICR; PHOSPHOTRANSFERASES; RECEPTORS, GLUTAMATE;

EID: 20244377072     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03058.x     Document Type: Article

References (51)

1. Amin N. D., Albers W. and Pant H. C. (2002) Cyclin-dependent kinase 5 (Cdk5) activation requires interaction with three domains of p35. J. Neurosci. Res. 67, 354-362.
2. Bibb J. A., Chen J., Taylor J. R. et al (1999) Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402, 669-671.
3. Bibb J. A., Nishi A., O'Callaghan J. P. et al. (2001) Phosphorylation of protein phosphatase inhibitor-1 by Cdk5. J. Biol. Chem. 276, 1 44 990-1 14 497.
4. Bortolotto Z. A., Clarke V. R., Delany C. M. et al. (1999) Kainate receptors are involved in synaptic plasticity. Nature 402, 297-301.
5. Bu B., Li J., Davies P. and Vincent I. (2002) Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci. 22, 6515-6525.
6. Caporaso G. L., Bibb J. A., Snyder G. L., Valle C., Rakhillin S., Fienberg A. A., Hemmings H. C., Nairn A. C. and Greengard P. (2000) Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia. Neuropharmacology 39, 1637-1644.
7. Chae T., Kwon Y. T., Bronson R., Dikkes P., Li E. and Tsai L.-H. (1997) Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18, 29-42.
8. Craig A. M. and Boudin H. (2001) Molecular heterogeneity of central synapses: afferent and target regulation. Nat. Neurosci. 4, 569-578.
9. Dhavan R. and Tsai L.-H. (2001) A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2, 749-759.
10. 2+-calmodulin-dependent protein kinase II and alph-actinin-1 in a calcium-dependent manner. J. Neurosci. 22, 7879-7891.
11. Fischer A., Sananbenesi F., Spiess J. and Radulovic J. (2003) Cdk5: a novel role in learning and memory. Neurosignals 12, 200-208.
12. Floyd S. R., Porro E. B., Slepnev V. I., Ochoa G. C., Tsai L.-H. and De Camilli P. (2001) Amphiphysin 1 binds the cyclin-dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2. J. Biol. Chem. 276, 8104-8110.
13. Harada T., Morooka T., Ogawa S. and Nishida E. (2001) ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat. Cell Biol. 3, 453-459.
14. Hashiguchi M., Saito T., Hisanaga S. and Hashiguchi T. (2002) Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau 40. J. Biol. Chem. 277, 44524-44 530.
15. Hisanaga S. and Saito T. (2003) The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator. Neurosignals 12, 221-229.
16. Kerokoski P., Suuronen T., Salminen A., Soininen H. and Pirttila T. (2002) Cleavage of the cyclin-dependnet kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation. Biochem. Biophys. Res. Commun. 298, 693-698.
17. Kusakawa G., Saito T., Onuki R., Ishiguro K., Kishimoto T. and Hisanaga S. (2000) Calpain-dependent proteolytic cleavage of the p35 CDK5 activator to p25. J. Biol. Chem. 275, 17 166-17 172.
18. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M. and Tsai L.-H. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364.
19. Li B. S., Zhang L., Gu J., Amin N. D. and Pant H. C. (2000) Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation. J. Neurosci. 20, 6055-6062.
20. Li B. S., Sun M.-K., Zhang L., Takahashi S., Ma W., Vinade L., Kulkarni A. B. and Pant H. C. (2001) Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc. Natl Acad. Sci. USA 98, 12 742-12 747.
21. Liu F., Ma X.-H., Ule J., Bibb J. A., Nishi A., DeMaggio A. J., Yan Z., Nairn A. C. and Greengard P. (2001) Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc. Natl Acad. Sci. USA 98, 11 062-11 068.
22. Lu Y.-R., Kojima N., Tomizawa K., Moriwaki A., Matsushita M., Obata K. and Matsui H. (1999) Enhanced synaptic transmission and reduced threshold for LTP induction in fyn-transgenic mice. Eur. J. Neurosci. 11, 75-82.
23. Matsubara M., Kusubata M., Ishiguro K., Uchida T., Titani K. and Taniguchi H. (1996) Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological function. J. Biol. Chem. 271, 21 108-21 1113.
24. Morabito M. A., Shen M. and Tsai L.-H. (2004) Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J. Neurosci. 24, 865-876.
25. Nath R., Davis M., Probert A. W., Kupina N. C., Ren X., Schielke G. P. and Wang K. K. W. (2000) Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. Biochem. Biophys. Res. Commun. 274, 16-21.
26. Nguyen C. and Bibb J. A. (2003) Cdk5 and the mystery of synaptic vesicle endocytosis. J. Cell Biol. 163, 697-699.
27. Nguyen M. D., Lariviere R. C. and Julien J. P. (2001) Deregulation of Cdk5 in a mouse model of ALS; toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30, 135-147.
28. Nikolic M., Dudek H., Kwon Y. T., Ramos Y. F. and Tsai L.-H. (1996) The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816-825.
29. Ohshima T., Ward J. M., Huh C.-G., Longenecker G., Veeranna Pant H. C., Brady R. O., Martin L. J. and Kulkami A. B. (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl Acad. Sci. USA 93, 11 173-11 178.
30. Ohshima T., Gilmore E. C., Longenecker G., Jacobowitz D. M., Brady R. O., Herrup K. and Kulkarni A. B. (1999) Migration defects of cdk5 (-/-) neurons in the developing cerebellum is cell autonomous. J. Neurosci. 19, 6017-6026.
31. Ohshima T., Ogawa M., Veeranna Hirasawa M., Longenecker G., Ishiguro K., Pant H. C., Brady R. O., Kulkami A. B. and Mikoshiba K. (2001) Synergistic contribution of Cdk5/p35 and Reelin/Dab1 to the positioning of cortical neurons in developing mouse brain. Proc. Natl Acad. Sci. USA 98, 2764-2769.
32. Ozawa S., Kamiya H. and Tsuzuki K. (1998) Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54, 581-618.
33. Paglini G., Pigino G., Kunda P., Morfini G., Maccioni R., Quiroga S., Fe A. and Caceres A. (1998) Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin enhanced axonal growth. J. Neurosci. 18, 9858-9869.
34. Patrick G. N., Zhou P., Kwon Y. T., Howley P. M. and Tsai L.-H. (1998) p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J. Biol. Chem. 273, 24 057-24 064.
35. Patrick G. N., Zukerberg L., Nikolik M., de la Monte S., Kikkes P. and Tsai L.-H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
36. Platenik J., Kuramoto N. and Yoneda Y (2000) Molecular mechanisms associated with long-term consolidation of the NMDA signals. Life Sci. 67, 335-364.
37. Saito T., Ishiguro K., Onuki R., Nagai Y., Kishimoto T. and Hisanaga S. (1998) Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons. Biochem. Biophys. Res. Commun. 252, 775-778.
38. Saito T., Onuki R., Fujita Y., Kusakawa G., Ishiguro K., Bibb J. A., Kishimoto T. and Hisanaga S. (2003) Developmental regulation of the proteolysis of the p35 Cdk5 activator by phosphorylation. J. Neurosci. 23, 1189-1197.
39. Sasaki Y., Cheng C., Uchida Y. et al. (2002) Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 35, 907-920.
40. Sharma P., Sharma M., Amin N. D., Albers R. W. and Pant H. C. (1999) Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proc. Natl Acad. Sci. USA 96, 11 156-11 160.
41. Tan T. C., Valova V. A., Malladi C. S. et al. (2003) Cdk5 is essential for synaptic vesicle endocytosis. Nat. Cell Biol. 8, 701-710.
42. Tang D. and Wang J. H. (1996) Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators. Prog. Cell Cycle Res. 2, 205-216.
43. Tang D., Chun A. C., Zhang M. and Wang J. H. (1997) Cyclin-dependent kinase 5 (Cdk5) activation domain of neuronal Cdk5 activator. Evidence of the existence of cyclin fold in neuronal Cdk5a activator. J. Biol. Chem. 272, 12318-12 327.
44. Tokuoka H., Saito T., Yorifuji H., Wei F.-Y., Kishimoto T. and Hisanaga S. (2000) BDNF-induced phosphorylation of neurofilament-H subunit in primary culture of rat cortical neurons. J. Cell Sci. 113, 1059-1068.
45. Tomizawa K., Ohta J., Matsushita M., Moriwaki A., Li S.-T., Takei K. and Matsui H. (2002) Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J. Neurosci. 22, 2590-2597.
46. Tomizawa K., Sunada S., Lu Y.-F. et al. (2003) Cdk5/p35-dependent phosphorylation of amphiphysin I and dynamin I: critical role in clathrin-mediated endocytosis of synaptic vesicles. J. Cell Biol. 163, 813-824.
47. Tsai L-H., Delalle I., Caviness V. S. Jr, Chae T. and Harlow E. (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-423.
48. Wada Y., Ishiguro K., Itoh T.J., Uchida T., Hotani H., Saito T., Kishimoto T. and Hisanaga S. (1998) Microtubule-stimulated phosphorylation of tau at Ser202 and Thr 205 by cdk5 decrease: its microtubule nucleation activity. J Biochem. (Tokyo) 124, 738-746.
49. Wang J., Liu S., Fu Y., Wang J. H. and Lu Y. (2003) Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat. Neurosci. 6, 1039-1047.
50. Yazawa M., Sakuma M. and Yagi K. (1980) Calmodulins from muscles of marine invertebrates, scallop and sea anemone. J. Biochem. (Tokyo) 87, 1313-1320.
51. Zukerberg L. R., Patrick G. N., Nikolic M., Humbert S., Wu C-L., Lanier L. M., Gertler F. B., Vidal M., Van Etten R. A. and Tsai L.-H. (2000) Cables links Cdk5 and c-Ab1 and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite out-growth. Neuron 26, 633-646.